FPX News and Press, First Trust US Equity Opportunities From 06/24/22

Biostage has filed to raise capital via an uplisting IPO to Nasdaq. The firm is developing treatments for the various gastrointestinal system and airway conditions. BSTG is still at the preclinical stage of development, so the IPO is ultra-high-risk. For further details see:...

CrowdStrike is a leading cloud-native cybersecurity company. Shares are almost 50% below their 52-week high, which is probably considered resilient for a high-growth tech company in the current market. I believe that CrowdStrike has the strongest business model of any company in m...

MusclePharm has filed to raise capital via an uplisting IPO to Nasdaq. The firm sells a variety of sports nutrition and functional energy products. MSLP has produced contracting revenue and significant operating losses. For further details see: MusclePharm Files For Upli...

Starbox Group Holdings Ltd. has filed proposed terms for a $22.5 million IPO. The Malaysia-based firm provides advertising services and a mobile platform for retailers to better connect with customers. STBX is a tiny company with limited operating history, and the IPO appears pric...

From the November peak to the recent trough, U.S. large cap growth stocks lost more than 30%, a decline on par with the pandemic induced bear market. Growth is still trailing the S&P 500 by roughly 10% and nearly 17% versus comparable value indexes. As economic growth slows, i...

CW Petroleum has filed to raise $17 million in an IPO. The firm distributes various types of fuel to wholesale customers in Southern Texas. CWPE has produced uneven financial results and wants to use the IPO proceeds to expand into convenience store ownership, among other uses. ...

NYIAX has filed proposed terms for a $20 million U.S. IPO. The company operates a marketplace for buying and selling advertising. NYX has produced tiny revenue, high operating losses and the IPO is priced for perfection. I'm on Hold for NYX although day traders may see high vo...

Uber's Mobility segment will likely see consumers opting for cheaper options, like public transportation, and less demand for discretionary rides when money is tight. The Delivery segment's pricing model could cause consumers to drive to the store themselves as the fees could bring th...

Growth stocks are under acute pressure as rising interest rates change the dynamics that drive equity valuations. Market corrections are always painful, but investors in growth equities have suffered a particularly harsh blow this year. This year’s market correction reflect...

MSCI U.S. Growth has underperformed its Value counterpart by 16% in the first 4 months of 2022 and had a tough end to 2021 as well. The fact that growth traps are more painful than value traps is, in one sense, not really a surprise. Value stocks are already companies that investors d...